{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:42:02Z","timestamp":1778802122082,"version":"3.51.4"},"reference-count":194,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2020,2,8]],"date-time":"2020-02-08T00:00:00Z","timestamp":1581120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/MED-GEN\/30356\/2017"],"award-info":[{"award-number":["PTDC\/MED-GEN\/30356\/2017"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/BIM-ONC\/0171\/2012"],"award-info":[{"award-number":["PTDC\/BIM-ONC\/0171\/2012"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["PTDC\/BIM-ONC\/0281\/2014"],"award-info":[{"award-number":["PTDC\/BIM-ONC\/0281\/2014"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The extracellular matrix (ECM) is a dynamic and highly organized tissue structure, providing support and maintaining normal epithelial architecture. In the last decade, increasing evidence has emerged demonstrating that alterations in ECM composition and assembly strongly affect cellular function and behavior. Even though the detailed mechanisms underlying cell-ECM crosstalk are yet to unravel, it is well established that ECM deregulation accompanies the development of many pathological conditions, such as gastric cancer. Notably, gastric cancer remains a worldwide concern, representing the third most frequent cause of cancer-associated deaths. Despite increased surveillance protocols, patients are usually diagnosed at advanced disease stages, urging the identification of novel diagnostic biomarkers and efficient therapeutic strategies. In this review, we provide a comprehensive overview regarding expression patterns of ECM components and cognate receptors described in normal gastric epithelium, pre-malignant lesions, and gastric carcinomas. Important insights are also discussed for the use of ECM-associated molecules as predictive biomarkers of the disease or as potential targets in gastric cancer.<\/jats:p>","DOI":"10.3390\/cells9020394","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T11:48:51Z","timestamp":1581335331000},"page":"394","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":92,"title":["The Extracellular Matrix: An Accomplice in Gastric Cancer Development and Progression"],"prefix":"10.3390","volume":"9","author":[{"given":"Ana Margarida","family":"Moreira","sequence":"first","affiliation":[{"name":"Epithelial Interactions in Cancer Group, i3S-Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, 4200-135 Porto, Portugal"},{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), 4200-135 Porto, Portugal"},{"name":"Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal"}]},{"given":"Joana","family":"Pereira","sequence":"additional","affiliation":[{"name":"Epithelial Interactions in Cancer Group, i3S-Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, 4200-135 Porto, Portugal"},{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), 4200-135 Porto, Portugal"},{"name":"Medical Faculty, University of Porto, 4200-319 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0278-0827","authenticated-orcid":false,"given":"Soraia","family":"Melo","sequence":"additional","affiliation":[{"name":"Epithelial Interactions in Cancer Group, i3S-Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, 4200-135 Porto, Portugal"},{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), 4200-135 Porto, Portugal"},{"name":"Medical Faculty, University of Porto, 4200-319 Porto, Portugal"}]},{"given":"Maria Sofia","family":"Fernandes","sequence":"additional","affiliation":[{"name":"Epithelial Interactions in Cancer Group, i3S-Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, 4200-135 Porto, Portugal"},{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), 4200-135 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4404-9343","authenticated-orcid":false,"given":"Patr\u00edcia","family":"Carneiro","sequence":"additional","affiliation":[{"name":"Epithelial Interactions in Cancer Group, i3S-Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, 4200-135 Porto, Portugal"},{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), 4200-135 Porto, Portugal"}]},{"given":"Raquel","family":"Seruca","sequence":"additional","affiliation":[{"name":"Epithelial Interactions in Cancer Group, i3S-Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, 4200-135 Porto, Portugal"},{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), 4200-135 Porto, Portugal"},{"name":"Medical Faculty, University of Porto, 4200-319 Porto, Portugal"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1590-1974","authenticated-orcid":false,"given":"Joana","family":"Figueiredo","sequence":"additional","affiliation":[{"name":"Epithelial Interactions in Cancer Group, i3S-Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto, 4200-135 Porto, Portugal"},{"name":"Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), 4200-135 Porto, Portugal"}]}],"member":"1968","published-online":{"date-parts":[[2020,2,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/nrm3902","article-title":"Extracellular matrix assembly: A multiscale deconstruction","volume":"15","author":"Mouw","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/nrm3896","article-title":"Mechanotransduction and extracellular matrix homeostasis","volume":"15","author":"Humphrey","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2748","article-title":"Integrins in cancer: Biological implications and therapeutic opportunities","volume":"10","author":"Desgrosellier","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/nrm3904","article-title":"Remodelling the extracellular matrix in development and disease","volume":"15","author":"Bonnans","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"a005066","DOI":"10.1101\/cshperspect.a005066","article-title":"Integrins and extracellular matrix in mechanotransduction","volume":"2","author":"Schwartz","year":"2010","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","article-title":"Every step of the way: Integrins in cancer progression and metastasis","volume":"18","author":"Hamidi","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF00189574","article-title":"Tenascin expression in inflammatory, dysplastic and neoplastic lesions of the human stomach","volume":"425","author":"Tiitta","year":"1994","journal-title":"Virchows Arch."},{"key":"ref_8","first-page":"3103","article-title":"COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer","volume":"20","author":"Jiang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.2147\/CMAR.S198331","article-title":"A panel of collagen genes are associated with prognosis of patients with gastric cancer and regulated by microRNA-29c-3p: An integrated bioinformatics analysis and experimental validation","volume":"11","author":"Zhang","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/ar.20874","article-title":"A potential role of collagens expression in distinguishing between premalignant and malignant lesions in stomach","volume":"292","author":"Zhao","year":"2009","journal-title":"Anat. Rec. (Hoboken)"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1242\/jcs.023820","article-title":"The extracellular matrix at a glance","volume":"123","author":"Frantz","year":"2010","journal-title":"J. Cell Sci."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ydbio.2009.10.026","article-title":"The extracellular matrix in development and morphogenesis: A dynamic view","volume":"341","author":"Rozario","year":"2010","journal-title":"Dev. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrgastro.2017.76","article-title":"The extracellular matrix of the gastrointestinal tract: A regenerative medicine platform","volume":"14","author":"Hussey","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1530\/JOE-10-0377","article-title":"Extracellular matrix and cell signalling: The dynamic cooperation of integrin, proteoglycan and growth factor receptor","volume":"209","author":"Kim","year":"2011","journal-title":"J. Endocrinol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2041731414557112","DOI":"10.1177\/2041731414557112","article-title":"The extracellular matrix: Structure, composition, age-related differences, tools for analysis and applications for tissue engineering","volume":"5","author":"Kular","year":"2014","journal-title":"J. Tissue Eng."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1124\/pr.109.001289","article-title":"Extracellular matrix molecules: Potential targets in pharmacotherapy","volume":"61","author":"Jarvelainen","year":"2009","journal-title":"Pharm. Rev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1083\/jcb.201102147","article-title":"The extracellular matrix: A dynamic niche in cancer progression","volume":"196","author":"Lu","year":"2012","journal-title":"J. Cell Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41580-019-0134-2","article-title":"Integrins as biomechanical sensors of the microenvironment","volume":"20","author":"Kechagia","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc2544","article-title":"A tense situation: Forcing tumour progression","volume":"9","author":"Butcher","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s10585-019-09966-1","article-title":"The extracellular matrix in tumor progression and metastasis","volume":"36","author":"Eble","year":"2019","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.devcel.2010.05.012","article-title":"Tumors as organs: Complex tissues that interface with the entire organism","volume":"18","author":"Egeblad","year":"2010","journal-title":"Dev. Cell"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s10555-008-9178-z","article-title":"Tissue architecture and function: Dynamic reciprocity via extra- and intra-cellular matrices","volume":"28","author":"Xu","year":"2009","journal-title":"Cancer Metastasis Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1242\/dmm.004077","article-title":"Remodeling and homeostasis of the extracellular matrix: Implications for fibrotic diseases and cancer","volume":"4","author":"Cox","year":"2011","journal-title":"Dis Model. Mech."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.1007\/s00018-010-0367-x","article-title":"Basement membrane components are key players in specialized extracellular matrices","volume":"67","author":"Kruegel","year":"2010","journal-title":"Cell Mol. Life Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1002\/(SICI)1097-0185(199608)245:4<668::AID-AR7>3.0.CO;2-K","article-title":"Differential expression of extracellular matrix components during the morphogenesis of human gastric mucosa","volume":"245","author":"Tremblay","year":"1996","journal-title":"Anat. Rec."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1113\/JP277195","article-title":"A novel role for the extracellular matrix glycoprotein-Tenascin-X in gastric function","volume":"597","author":"Aktar","year":"2019","journal-title":"J. Physiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1679\/aohc.70.313","article-title":"The differential distribution of type IV collagen alpha chains in the subepithelial basement membrane of the human alimentary canal","volume":"70","author":"Sato","year":"2007","journal-title":"Arch. Histol. Cytol."},{"key":"ref_28","first-page":"a004978","article-title":"The collagen family","volume":"3","year":"2011","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"26172","DOI":"10.1016\/S0021-9258(18)47174-8","article-title":"Complete primary structure of the human type IV collagen alpha 4(IV) chain. Comparison with structure and expression of the other alpha (IV) chains","volume":"269","author":"Leinonen","year":"1994","journal-title":"J. Biol. Chem."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1146\/annurev-cellbio-101011-155750","article-title":"Functional diversity of laminins","volume":"28","author":"Domogatskaya","year":"2012","journal-title":"Annu Rev. Cell Dev. Biol."},{"key":"ref_31","first-page":"1123","article-title":"Differential expression of laminin chains and their integrin receptors in human gastric mucosa","volume":"147","author":"Virtanen","year":"1995","journal-title":"Am. J. Pathol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.matbio.2005.06.008","article-title":"Fibronectin fibrillogenesis, a cell-mediated matrix assembly process","volume":"24","author":"Mao","year":"2005","journal-title":"Matrix Biol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"3861","DOI":"10.1242\/jcs.00059","article-title":"Fibronectin at a glance","volume":"115","author":"Pankov","year":"2002","journal-title":"J. Cell Sci."},{"key":"ref_34","first-page":"57","article-title":"Collagen mRNA and fibronectin are increased in healing gastric ulcers in man","volume":"46","author":"Gillessen","year":"1995","journal-title":"J. Physiol. Pharm."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: The next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Mohan, V., Das, A., and Sagi, I. (2019). Emerging roles of ECM remodeling processes in cancer. Semin. Cancer Biol.","DOI":"10.1016\/j.semcancer.2019.09.004"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.15252\/embr.201439246","article-title":"The extracellular matrix modulates the hallmarks of cancer","volume":"15","author":"Pickup","year":"2014","journal-title":"EMBO Rep."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","article-title":"The Two Histological Main Types of Gastric Carcinoma: Diffuse and So-Called Intestinal-Type Carcinoma. An Attempt at a Histo-Clinical Classification","volume":"64","author":"Lauren","year":"1965","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bpg.2006.03.016","article-title":"Pathology and molecular biology of gastric cancer","volume":"20","author":"Vauhkonen","year":"2006","journal-title":"Best Pr. Res. Clin. Gastroenterol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(09)60617-6","article-title":"Gastric cancer","volume":"374","author":"Hartgrink","year":"2009","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0344-0338(11)80878-2","article-title":"New elements for an updated classification of the carcinomas of the stomach","volume":"191","author":"Carneiro","year":"1995","journal-title":"Pathol. Res. Pr."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1002\/1097-0142(197706)39:6<2475::AID-CNCR2820390626>3.0.CO;2-L","article-title":"Gastric carcinoma. A pathobiological classification","volume":"39","author":"Ming","year":"1977","journal-title":"Cancer"},{"key":"ref_43","first-page":"3554","article-title":"A human model of gastric carcinogenesis","volume":"48","author":"Correa","year":"1988","journal-title":"Cancer Res."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1751-2980.2011.00550.x","article-title":"The gastric precancerous cascade","volume":"13","author":"Correa","year":"2012","journal-title":"J. Dig. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.tcb.2008.08.007","article-title":"Breaching the basement membrane: Who, when and how?","volume":"18","author":"Rowe","year":"2008","journal-title":"Trends Cell Biol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1083-4389.2004.00232.x","article-title":"Increased production of matrix metalloproteinases in Helicobacter pylori-associated human gastritis","volume":"9","author":"Bergin","year":"2004","journal-title":"Helicobacter"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/infdis\/jiw031","article-title":"Helicobacter pylori Activates Matrix Metalloproteinase 10 in Gastric Epithelial Cells via EGFR and ERK-mediated Pathways","volume":"213","author":"Costa","year":"2016","journal-title":"J. Infect. Dis."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"34888","DOI":"10.1074\/jbc.M607067200","article-title":"Helicobacter pylori induces gastric epithelial cell invasion in a c-Met and type IV secretion system-dependent manner","volume":"281","author":"Oliveira","year":"2006","journal-title":"J. Biol. Chem."},{"key":"ref_49","first-page":"515","article-title":"Expression of matrix metalloproteinases MMP-2 and MMP-9 in gastric cancer and their relation to claudin-4 expression","volume":"23","author":"Lee","year":"2008","journal-title":"Histol. Histopathol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00432-014-1630-6","article-title":"The prognostic role of matrix metalloproteinase 2 in gastric cancer: A systematic review with meta-analysis","volume":"140","author":"Shen","year":"2014","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_51","first-page":"166","article-title":"Relationships between abnormal MMP2 expression and prognosis in gastric cancer: A meta-analysis of cohort studies","volume":"29","author":"Wang","year":"2014","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Soleyman-Jahi, S., Nedjat, S., Abdirad, A., Hoorshad, N., Heidari, R., and Zendehdel, K. (2014). Prognostic significance of matrix metalloproteinase-7 in gastric cancer survival: A meta-analysis. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0122316"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3892\/ol.2014.2768","article-title":"Expression levels of matrix metalloproteinase-9 in human gastric carcinoma","volume":"9","author":"Chen","year":"2015","journal-title":"Oncol. Lett."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1515\/CCLM.2009.212","article-title":"Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers","volume":"47","author":"Emara","year":"2009","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_55","first-page":"6495","article-title":"Expression of matrix metalloproteinase-9, cyclooxygenase-2 and vascular endothelial growth factor are increased in gastrointestinal stromal tumors","volume":"8","author":"Liu","year":"2015","journal-title":"Int J. Clin. Exp. Med."},{"key":"ref_56","first-page":"518","article-title":"Prognostic value of matrix metalloproteinase-9 in gastric cancer: A meta-analysis","volume":"61","author":"Chen","year":"2014","journal-title":"Hepatogastroenterology"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1158\/1940-6207.CAPR-14-0229","article-title":"Urinary ADAM12 and MMP-9\/NGAL complex detect the presence of gastric cancer","volume":"8","author":"Shimura","year":"2015","journal-title":"Cancer Prev. Res. (Phila)"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3892\/ol.2014.1910","article-title":"Overexpression of collagen VI alpha3 in gastric cancer","volume":"7","author":"Xie","year":"2014","journal-title":"Oncol. Lett."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000081726","article-title":"Deregulation of collagen metabolism in human stomach cancer","volume":"71","author":"Guszczyn","year":"2004","journal-title":"Pathobiology"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1039\/C8BM00843D","article-title":"Increased extracellular matrix density disrupts E-cadherin\/beta-catenin complex in gastric cancer cells","volume":"6","author":"Jang","year":"2018","journal-title":"Biomater. Sci."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1053\/j.gastro.2009.02.003","article-title":"Laminin gamma2 mediates Wnt5a-induced invasion of gastric cancer cells","volume":"137","author":"Yamamoto","year":"2009","journal-title":"Gastroenterology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1093\/hmg\/ddv312","article-title":"E-cadherin-defective gastric cancer cells depend on Laminin to survive and invade","volume":"24","author":"Caldeira","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/ijc.30801","article-title":"Cancer-associated fibroblast-derived Lumican promotes gastric cancer progression via the integrin beta1-FAK signaling pathway","volume":"141","author":"Wang","year":"2017","journal-title":"Int. J. Cancer"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/sj.bjc.6604760","article-title":"Fibulin 1 is downregulated through promoter hypermethylation in gastric cancer","volume":"99","author":"Cheng","year":"2008","journal-title":"Br. J. Cancer"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"152553","DOI":"10.1016\/j.prp.2019.152553","article-title":"NID2 can serve as a potential prognosis prediction biomarker and promotes the invasion and migration of gastric cancer","volume":"215","author":"Yu","year":"2019","journal-title":"Pathol. Res. Pr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.3748\/wjg.14.2110","article-title":"Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer","volume":"14","author":"Liu","year":"2008","journal-title":"World J. Gastroenterol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"9927","DOI":"10.1002\/jcb.28275","article-title":"Overexpression of periostin is positively associated with gastric cancer metastasis through promoting tumor metastasis and invasion","volume":"120","author":"Zhong","year":"2019","journal-title":"J. Cell Biochem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1357-2725(02)00264-9","article-title":"Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma","volume":"35","author":"Theocharis","year":"2003","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1258\/ebm.2011.011124","article-title":"Biglycan expression correlates with aggressiveness and poor prognosis of gastric cancer","volume":"236","author":"Wang","year":"2011","journal-title":"Exp. Biol. Med. (Maywood)"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1007\/s10517-019-04438-8","article-title":"Immunistochemical Analysis of the Expression of TGFbeta, Galectin-1, Vimentin, and Thrombospondin in Gastric Cancer Associated with Systemic Undifferentiated Connective Tissue Dysplasia","volume":"166","author":"Naumova","year":"2019","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1007\/s00018-009-8632-6","article-title":"Fibulins: Multiple roles in matrix structures and tissue functions","volume":"66","author":"Iwamoto","year":"2009","journal-title":"Cell Mol. Life Sci."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"a004903","DOI":"10.1101\/cshperspect.a004903","article-title":"Overview of the matrisome--an inventory of extracellular matrix constituents and functions","volume":"4","author":"Hynes","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.ajpath.2013.11.012","article-title":"The niche component periostin is produced by cancer-associated fibroblasts, supporting growth of gastric cancer through ERK activation","volume":"184","author":"Kikuchi","year":"2014","journal-title":"Am. J. Pathol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/nature10694","article-title":"Interactions between cancer stem cells and their niche govern metastatic colonization","volume":"481","author":"Malanchi","year":"2011","journal-title":"Nature"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/bjc.2017.458","article-title":"A core matrisome gene signature predicts cancer outcome","volume":"118","author":"Yuzhalin","year":"2018","journal-title":"Br. J. Cancer"},{"key":"ref_76","first-page":"2569","article-title":"Distinctive patterns of gene expression in premalignant gastric mucosa and gastric cancer","volume":"63","author":"Boussioutas","year":"2003","journal-title":"Cancer Res."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"6830","DOI":"10.1038\/sj.onc.1207886","article-title":"Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray","volume":"23","author":"Jinawath","year":"2004","journal-title":"Oncogene"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"8069","DOI":"10.1002\/jcb.28085","article-title":"Systematic analysis of multigene predictors in gastric cancer exploiting gene expression signature","volume":"120","author":"Ai","year":"2018","journal-title":"J. Cell Biochem."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1749-6632.1998.tb10112.x","article-title":"Fibronectin and integrins in cell adhesion, signaling, and morphogenesis","volume":"857","author":"Miyamoto","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jcp.21237","article-title":"Cell-matrix adhesion","volume":"213","author":"Berrier","year":"2007","journal-title":"J. Cell Physiol."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1146\/annurev-cellbio-100109-104104","article-title":"Regulation of integrin activation","volume":"27","author":"Kim","year":"2011","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1083\/jcb.201212037","article-title":"Complete integrin headpiece opening in eight steps","volume":"201","author":"Zhu","year":"2013","journal-title":"J. Cell Biol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1242\/jcs.01014","article-title":"Integrin activation","volume":"117","author":"Calderwood","year":"2004","journal-title":"J. Cell Sci."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1081\/CNV-120000374","article-title":"Order and disorder: The role of extracellular matrix in epithelial cancer","volume":"20","author":"Radisky","year":"2002","journal-title":"Cancer Invest."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1146\/annurev.cellbio.12.1.697","article-title":"RGD and other recognition sequences for integrins","volume":"12","author":"Ruoslahti","year":"1996","journal-title":"Annu Rev. Cell Dev. Biol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3901","DOI":"10.1242\/jcs.03098","article-title":"Integrin ligands at a glance","volume":"119","author":"Humphries","year":"2006","journal-title":"J. Cell Sci."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1042\/bj3390481","article-title":"Extracellular matrix and integrin signalling: The shape of things to come","volume":"339 Pt. 3","author":"Boudreau","year":"1999","journal-title":"Biochem J."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrm3769","article-title":"The integrin adhesome: From genes and proteins to human disease","volume":"15","author":"Fassler","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1750-1172-1-10","article-title":"Glanzmann thrombasthenia","volume":"1","author":"Nurden","year":"2006","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1084\/jem.160.6.1901","article-title":"Inherited deficiency of the Mac-1, LFA-1, p150,95 glycoprotein family and its molecular basis","volume":"160","author":"Springer","year":"1984","journal-title":"J. Exp. Med."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0092-8674(87)90215-7","article-title":"Heterogeneous mutations in the beta subunit common to the LFA-1, Mac-1, and p150,95 glycoproteins cause leukocyte adhesion deficiency","volume":"50","author":"Kishimoto","year":"1987","journal-title":"Cell"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/nrm3599","article-title":"Integrin inactivators: Balancing cellular functions in vitro and in vivo","volume":"14","author":"Bouvard","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/jcp.25821","article-title":"Understanding the role of structural integrity and differential expression of integrin profiling to identify potential therapeutic targets in breast cancer","volume":"233","author":"Das","year":"2018","journal-title":"J. Cell Physiol."},{"key":"ref_94","doi-asserted-by":"crossref","unstructured":"Nieberler, M., Reuning, U., Reichart, F., Notni, J., Wester, H.J., Schwaiger, M., Weinmuller, M., Rader, A., Steiger, K., and Kessler, H. (2017). Exploring the Role of RGD-Recognizing Integrins in Cancer. Cancers (Basel), 9.","DOI":"10.3390\/cancers9090116"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1038\/sj.emboj.7601738","article-title":"Increased tumor cell dissemination and cellular senescence in the absence of beta1-integrin function","volume":"26","author":"Kren","year":"2007","journal-title":"EMBO J."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ccr.2004.06.025","article-title":"Targeted disruption of beta1-integrin in a transgenic mouse model of human breast cancer reveals an essential role in mammary tumor induction","volume":"6","author":"White","year":"2004","journal-title":"Cancer Cell"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1476-4598-9-152","article-title":"Integrin expression profiling identifies integrin alpha5 and beta1 as prognostic factors in early stage non-small cell lung cancer","volume":"9","author":"Dingemans","year":"2010","journal-title":"Mol. Cancer"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1078\/0344-0338-00355","article-title":"Expression of alphav integrin family in gastric carcinomas: Increased alphavbeta6 is associated with lymph node metastasis","volume":"199","author":"Kawashima","year":"2003","journal-title":"Pathol. Res. Pr."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"3852","DOI":"10.3748\/wjg.v22.i14.3852","article-title":"Integrin alphavbeta6 and matrix metalloproteinase 9 correlate with survival in gastric cancer","volume":"22","author":"Lian","year":"2016","journal-title":"World J. Gastroenterol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.clon.2007.09.008","article-title":"Integrin alphanvbeta6 acts as a prognostic indicator in gastric carcinoma","volume":"20","author":"Zhang","year":"2008","journal-title":"Clin. Oncol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.canlet.2009.06.006","article-title":"Vascular endothelial growth factor (VEGF) enhances gastric carcinoma invasiveness via integrin alpha(v)beta6","volume":"287","author":"Zhao","year":"2010","journal-title":"Cancer Lett."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s12032-013-0580-1","article-title":"Clinical significance of integrin alphavbeta6 expression effects on gastric carcinoma invasiveness and progression via cancer-associated fibroblasts","volume":"30","author":"Zhuang","year":"2013","journal-title":"Med. Oncol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1349-7006.2008.00762.x","article-title":"Integrin alpha v beta 6 mediates the potential for colon cancer cells to colonize in and metastasize to the liver","volume":"99","author":"Yang","year":"2008","journal-title":"Cancer Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/sj.bjc.6600480","article-title":"Integrin alpha(v)beta6-associated ERK2 mediates MMP-9 secretion in colon cancer cells","volume":"87","author":"Gu","year":"2002","journal-title":"Br. J. Cancer"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/BF02483952","article-title":"Separate functions of alpha2beta1 and alpha3beta1 integrins in the metastatic process of human gastric carcinoma","volume":"28","author":"Ura","year":"1998","journal-title":"Surg. Today"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"34594","DOI":"10.1074\/jbc.M706600200","article-title":"Elevated expression of Cyr61 enhances peritoneal dissemination of gastric cancer cells through integrin alpha2beta1","volume":"282","author":"Lin","year":"2007","journal-title":"J. Biol. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s12094-013-1133-y","article-title":"Increased expression of alpha5beta1-integrin is a prognostic marker for patients with gastric cancer","volume":"16","author":"Ren","year":"2014","journal-title":"Clin. Transl. Oncol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s10120-014-0435-2","article-title":"Integrins alphavbeta3 and alphavbeta5 as prognostic, diagnostic, and therapeutic targets in gastric cancer","volume":"18","author":"Boger","year":"2015","journal-title":"Gastric Cancer"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1007\/s00018-011-0778-3","article-title":"CCN1\/CYR61: The very model of a modern matricellular protein","volume":"68","author":"Lau","year":"2011","journal-title":"Cell Mol. Life Sci."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/nrd3599","article-title":"Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets","volume":"10","author":"Jun","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12079-016-0324-z","article-title":"Cell surface receptors for CCN proteins","volume":"10","author":"Lau","year":"2016","journal-title":"J. Cell Commun Signal."},{"key":"ref_112","first-page":"8917","article-title":"Elevated levels of connective tissue growth factor, WISP-1, and CYR61 in primary breast cancers associated with more advanced features","volume":"61","author":"Xie","year":"2001","journal-title":"Cancer Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1242\/jcs.071985","article-title":"Integrin alpha5beta1 facilitates cancer cell invasion through enhanced contractile forces","volume":"124","author":"Mierke","year":"2011","journal-title":"J. Cell Sci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ijc.20116","article-title":"CNTO 95, a fully human monoclonal antibody that inhibits alphav integrins, has antitumor and antiangiogenic activity in vivo","volume":"110","author":"Trikha","year":"2004","journal-title":"Int. J. Cancer"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10585-007-9132-4","article-title":"CNTO 95, a fully human anti alphav integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells","volume":"25","author":"Chen","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0016-5085(00)70255-1","article-title":"Integrin alpha6beta4 as a suppressor and a predictive marker for peritoneal dissemination in human gastric cancer","volume":"118","author":"Ishii","year":"2000","journal-title":"Gastroenterology"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Bianconi, D., Unseld, M., and Prager, G.W. (2016). Integrins in the Spotlight of Cancer. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17122037"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"179","DOI":"10.4161\/cam.3.2.8036","article-title":"Integrin switching modulates adhesion dynamics and cell migration","volume":"3","author":"Truong","year":"2009","journal-title":"Cell Adhes. Migr."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nrm1490","article-title":"Integrin signalling during tumour progression","volume":"5","author":"Guo","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1172\/JCI42328","article-title":"The \u03b12\u03b21 integrin is a metastasis suppressor in mouse models and human cancer","volume":"121","author":"Ramirez","year":"2011","journal-title":"J. Clin. Investig."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13058-019-1146-8","article-title":"Absence of integrin \u03b13\u03b21 promotes the progression of HER2-driven breast cancer in vivo","volume":"21","author":"Ramovs","year":"2019","journal-title":"Breast Cancer Res. Bcr."},{"key":"ref_122","first-page":"901","article-title":"High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival","volume":"55","author":"Friedrichs","year":"1995","journal-title":"Cancer Res."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1038\/modpathol.3800411","article-title":"Beta4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer","volume":"18","author":"Diaz","year":"2005","journal-title":"Mod. Pathol"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"5821","DOI":"10.1158\/0008-5472.CAN-06-4499","article-title":"Tumor alphavbeta3 integrin is a therapeutic target for breast cancer bone metastases","volume":"67","author":"Zhao","year":"2007","journal-title":"Cancer Res."},{"key":"ref_125","first-page":"839","article-title":"Integrin traffic\u2014the update","volume":"128","author":"Hamidi","year":"2015","journal-title":"J. Cell Sci."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.12688\/f1000research.11877.1","article-title":"Beyond adhesion: emerging roles for integrins in control of the tumor microenvironment","volume":"6","author":"Longmate","year":"2017","journal-title":"F1000Research"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1038\/ncb3257","article-title":"Definition of a consensus integrin adhesome and its dynamics during adhesion complex assembly and disassembly","volume":"17","author":"Horton","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"ref_128","first-page":"1680","article-title":"Autophosphorylation of the focal adhesion kinase, pp125FAK, directs SH2-dependent binding of pp60src","volume":"14","author":"Schaller","year":"1994","journal-title":"Mol. Cell. Biol."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-4889(01)00123-9","article-title":"Biochemical signals and biological responses elicited by the focal adhesion kinase","volume":"1540","author":"Schaller","year":"2001","journal-title":"Biochim. Et Biophys. Acta (Bba) Mol. Cell Res."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S1357-2725(97)00051-4","article-title":"Role of focal adhesion kinase in integrin signaling","volume":"29","author":"Guan","year":"1997","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","article-title":"Integrin-regulated FAK\u2013Src signaling in normal and cancer cells","volume":"18","author":"Mitra","year":"2006","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1091\/mbc.11.7.2485","article-title":"Integrin alpha5\/beta1 mediates fibronectin-dependent epithelial cell proliferation through epidermal growth factor receptor activation","volume":"11","author":"Kuwada","year":"2000","journal-title":"Mol. Biol. Cell"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1049\/iet-syb:20060058","article-title":"Integrin-mediated signaling through the MAP-kinase pathway","volume":"2","author":"Yee","year":"2008","journal-title":"IET Syst. Biol."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.tibs.2011.03.006","article-title":"The Ras-ERK and PI3K-mTOR pathways: Cross-talk and compensation","volume":"36","author":"Mendoza","year":"2011","journal-title":"Trends Biochem. Sci."},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1582-4934.2005.tb00337.x","article-title":"The activation of Akt\/PKB signaling pathway and cell survival","volume":"9","author":"Song","year":"2005","journal-title":"J. Cell. Mol. Med."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.cell.2012.03.017","article-title":"mTOR signaling in growth control and disease","volume":"149","author":"Laplante","year":"2012","journal-title":"Cell"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1093\/emboj\/cdg245","article-title":"The integrin-actin connection, an eternal love affair","volume":"22","author":"Brakebusch","year":"2003","journal-title":"EMBO J."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1242\/jcs.114.15.2713","article-title":"Rho GTPases and cell migration","volume":"114","author":"Ridley","year":"2001","journal-title":"J. Cell Sci."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.2353\/ajpath.2010.100172","article-title":"Phosphorylation of focal adhesion kinase at Tyr397 in gastric carcinomas and its clinical significance","volume":"177","author":"Lai","year":"2010","journal-title":"Am. J. Pathol."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.chom.2011.05.007","article-title":"Serine phosphorylation of cortactin controls focal adhesion kinase activity and cell scattering induced by Helicobacter pylori","volume":"9","author":"Tegtmeyer","year":"2011","journal-title":"Cell Host Microbe"},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1462-5822.2006.00856.x","article-title":"The Helicobacter pylori CagA protein disrupts matrix adhesion of gastric epithelial cells by dephosphorylation of vinculin","volume":"9","author":"Moese","year":"2007","journal-title":"Cell Microbiol."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s10330-009-0052-4","article-title":"The expressions and interrelation of p130Cas and PTEN in gastric cancer","volume":"8","author":"Wang","year":"2009","journal-title":"Chin. Ger. J. Clin. Oncol."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/1479-5876-11-277","article-title":"Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer","volume":"11","author":"Chen","year":"2013","journal-title":"J. Transl. Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3892\/ol.2013.1686","article-title":"Paxillin expression is closely linked to the pathogenesis, progression and prognosis of gastric carcinomas","volume":"7","author":"Xiao","year":"2014","journal-title":"Oncol. Lett."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ceb.2011.10.004","article-title":"Integrin inside-out signaling and the immunological synapse","volume":"24","author":"Springer","year":"2012","journal-title":"Curr. Opin. Cell Biol."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.amjsurg.2011.06.050","article-title":"Kindlin-2: A novel adhesion protein related to tumor invasion, lymph node metastasis, and patient outcome in gastric cancer","volume":"203","author":"Shen","year":"2012","journal-title":"Am. J. Surg."},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/jso.23353","article-title":"Novel focal adhesion protein kindlin-2 promotes the invasion of gastric cancer cells through phosphorylation of integrin beta1 and beta3","volume":"108","author":"Shen","year":"2013","journal-title":"J. Surg. Oncol."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1083\/jcb.201609037","article-title":"Integrin-mediated mechanotransduction","volume":"215","author":"Sun","year":"2016","journal-title":"J. Cell Biol."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.bbamem.2013.07.017","article-title":"Mechanisms of talin-dependent integrin signaling and crosstalk","volume":"1838","author":"Das","year":"2014","journal-title":"Biochim. Et Biophys. Acta"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1126\/science.1163865","article-title":"The Tail of Integrins, Talin, and Kindlins","volume":"324","author":"Moser","year":"2009","journal-title":"Science"},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s11684-014-0317-3","article-title":"Talin and kindlin: The one-two punch in integrin activation","volume":"8","author":"Ye","year":"2014","journal-title":"Front. Med."},{"key":"ref_152","doi-asserted-by":"crossref","unstructured":"Kahner, B.N., Kato, H., Banno, A., Ginsberg, M.H., Shattil, S.J., and Ye, F. (2012). Kindlins, Integrin Activation and the Regulation of Talin Recruitment to \u03b1IIb\u03b23. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0034056"},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.1200\/JCO.2008.16.7510","article-title":"Randomized phase II study of cilengitide, an integrin-targeting arginine-glycine-aspartic acid peptide, in recurrent glioblastoma multiforme","volume":"26","author":"Reardon","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10637-007-9077-0","article-title":"Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumors","volume":"26","author":"Delbaldo","year":"2008","journal-title":"Invest. New Drugs"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3816\/CGC.2006.n.012","article-title":"Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: Scientific rationale and study design","volume":"4","author":"Beekman","year":"2006","journal-title":"Clin. Genitourin. Cancer"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"7851","DOI":"10.1158\/1078-0432.CCR-05-0262","article-title":"Phase I trial of a monoclonal antibody specific for alphavbeta3 integrin (MEDI-522) in patients with advanced malignancies, including an assessment of effect on tumor perfusion","volume":"11","author":"McNeel","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_157","doi-asserted-by":"crossref","unstructured":"Raab-Westphal, S., Marshall, J.F., and Goodman, S.L. (2017). Integrins as Therapeutic Targets: Successes and Cancers. Cancers (Basel), 9.","DOI":"10.3390\/cancers9090110"},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"2825","DOI":"10.1242\/jcs.108.8.2825","article-title":"An anti-alpha v-integrin antibody that blocks integrin function inhibits the development of a human melanoma in nude mice","volume":"108 Pt. 8","author":"Mitjans","year":"1995","journal-title":"J. Cell Sci."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/annonc\/mdu474","article-title":"Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: The randomised phase I\/II POSEIDON trial","volume":"26","author":"Elez","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/bjc.2011.183","article-title":"phase II study of intetumumab, an anti-alphav-integrin mAb, alone and with dacarbazine in stage IV melanoma","volume":"105","author":"Pavlick","year":"2011","journal-title":"Br. J. Cancer"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/annonc\/mds505","article-title":"A randomized, double-blind, multicenter, phase 2 study of a human monoclonal antibody to human alphanu integrins (intetumumab) in combination with docetaxel and prednisone for the first-line treatment of patients with metastatic castration-resistant prostate cancer","volume":"24","author":"Heidenreich","year":"2013","journal-title":"Ann. Oncol."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1158\/0008-5472.CAN-07-2307","article-title":"Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism","volume":"68","author":"Leone","year":"2008","journal-title":"Cancer Res."},{"key":"ref_163","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00228-018-2435-3","article-title":"Safety, tolerability and pharmacokinetics of GSK3008348, a novel integrin alphavbeta6 inhibitor, in healthy participants","volume":"74","author":"Maden","year":"2018","journal-title":"Eur. J. Clin. Pharm."},{"key":"ref_164","first-page":"21","article-title":"Increased expression of alpha2beta1-integrin in the peritoneal dissemination of human gastric carcinoma","volume":"5","author":"Matsuoka","year":"2000","journal-title":"Int. J. Mol. Med."},{"key":"ref_165","first-page":"809","article-title":"Significance of integrin alpha2\/beta1 in peritoneal dissemination of a human gastric cancer xenograft model","volume":"18","author":"Kawamura","year":"2001","journal-title":"Int. J. Oncol."},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.semcancer.2015.08.004","article-title":"Alpha2beta1 integrin in cancer development and chemoresistance","volume":"35","author":"Naci","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"ref_167","first-page":"6116","article-title":"Sulfonamide derivative, E7820, is a unique angiogenesis inhibitor suppressing an expression of integrin alpha2 subunit on endothelium","volume":"62","author":"Funahashi","year":"2002","journal-title":"Cancer Res."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10637-016-0344-9","article-title":"A phase I, dose escalation, pharmacodynamic, pharmacokinetic, and food-effect study of alpha2 integrin inhibitor E7820 in patients with advanced solid tumors","volume":"34","author":"Slater","year":"2016","journal-title":"Invest. New Drugs"},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"217","DOI":"10.7555\/JBR.30.2016K0005","article-title":"Novel monoclonal antibody against beta 1 integrin enhances cisplatin efficacy in human lung adenocarcinoma cells","volume":"30","author":"Kim","year":"2016","journal-title":"J. Biomed. Res."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","article-title":"Extracellular matrix structure","volume":"97","author":"Theocharis","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1172\/JCI45817","article-title":"Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors","volume":"122","author":"Salmon","year":"2012","journal-title":"J. Clin. Investig."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.ygyno.2005.12.020","article-title":"A phase III randomized trial of BAY 12-9566 (tanomastat) as maintenance therapy in patients with advanced ovarian cancer responsive to primary surgery and paclitaxel\/platinum containing chemotherapy: A National Cancer Institute of Canada Clinical Trials Group Study","volume":"102","author":"Hirte","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bjc.6600446","article-title":"A double-blind placebo-controlled, randomised study comparing gemcitabine and marimastat with gemcitabine and placebo as first line therapy in patients with advanced pancreatic cancer","volume":"87","author":"Bramhall","year":"2002","journal-title":"Br. J. Cancer"},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1200\/JCO.2004.08.054","article-title":"Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196","volume":"22","author":"Sparano","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S0748-7983(97)93077-8","article-title":"Phase I\/II trial of batimastat, a matrix metalloproteinase inhibitor, in patients with malignant ascites","volume":"23","author":"Parsons","year":"1997","journal-title":"Eur. J. Surg. Oncol."},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1158\/1535-7163.MCT-17-0646","article-title":"Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes","volume":"17","author":"Winer","year":"2018","journal-title":"Mol. Cancer"},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0945-053X(98)90012-9","article-title":"Lysyl oxidase: Properties, regulation and multiple functions in biology","volume":"16","author":"Kagan","year":"1998","journal-title":"Matrix Biol."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1158\/0008-5472.CAN-12-2233","article-title":"LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis","volume":"73","author":"Cox","year":"2013","journal-title":"Cancer Res."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/nm.2208","article-title":"Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment","volume":"16","author":"Spangler","year":"2010","journal-title":"Nat. Med."},{"key":"ref_180","first-page":"245","article-title":"High expression of transform growth factor beta 1 in gastric cancer confers worse outcome: Results of a cohort study on 184 patients","volume":"61","author":"Hu","year":"2014","journal-title":"Hepatogastroenterology"},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1749-6632.1990.tb17931.x","article-title":"Transforming growth factor-beta. Major role in regulation of extracellular matrix","volume":"580","author":"Roberts","year":"1990","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1073\/pnas.85.4.1105","article-title":"Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability","volume":"85","author":"Penttinen","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_183","doi-asserted-by":"crossref","unstructured":"Morris, J.C., Tan, A.R., Olencki, T.E., Shapiro, G.I., Dezube, B.J., Reiss, M., Hsu, F.J., Berzofsky, J.A., and Lawrence, D.P. (2014). Phase I study of GC1008 (fresolimumab): A human anti-transforming growth factor-beta (TGFbeta) monoclonal antibody in patients with advanced malignant melanoma or renal cell carcinoma. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0090353"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1172\/JCI77958","article-title":"Fresolimumab treatment decreases biomarkers and improves clinical symptoms in systemic sclerosis patients","volume":"125","author":"Rice","year":"2015","journal-title":"J. Clin. Investig."},{"key":"ref_185","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.ekir.2017.03.011","article-title":"Focal Segmental Glomerulosclerosis Study, G., A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis","volume":"2","author":"Vincenti","year":"2017","journal-title":"Kidney Int. Rep."},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.med.57.121304.131306","article-title":"Angiogenesis","volume":"57","author":"Folkman","year":"2006","journal-title":"Annu. Rev. Med."},{"key":"ref_187","first-page":"623939","article-title":"Correlation of serum levels of endostatin with tumor stage in gastric cancer: A systematic review and meta-analysis","volume":"2015","author":"Wang","year":"2015","journal-title":"Biomed. Res. Int."},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.7314\/APJCP.2015.16.9.4037","article-title":"Clinical observation on recombinant human endostatin combined with chemotherapy for advanced gastrointestinal cancer","volume":"16","author":"Gao","year":"2015","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"70788","DOI":"10.18632\/oncotarget.19989","article-title":"Clinical efficacy of endostar combined with chemotherapy in the treatment of peritoneal carcinomatosis in gastric cancer: Results from a retrospective study","volume":"8","author":"Yao","year":"2017","journal-title":"Oncotarget"},{"key":"ref_190","first-page":"5060","article-title":"Identification of a potent peptide antagonist to an active laminin-1 sequence that blocks angiogenesis and tumor growth","volume":"63","author":"Ponce","year":"2003","journal-title":"Cancer Res."},{"key":"ref_191","first-page":"319","article-title":"Resolution of Gastric Cancer-Promoting Inflammation: A Novel Strategy for Anti-cancer Therapy","volume":"421","author":"Piazuelo","year":"2019","journal-title":"Curr Top. Microbiol. Immunol."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4251\/wjgo.v11.i9.686","article-title":"Tumor progression-dependent angiogenesis in gastric cancer and its potential application","volume":"11","author":"Hsieh","year":"2019","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(13)61719-5","article-title":"Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): An international, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"383","author":"Fuchs","year":"2014","journal-title":"Lancet"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/ajco.13174","article-title":"Anti-angiogenic therapies for gastric cancer","volume":"15","author":"Hironaka","year":"2019","journal-title":"Asia Pac. J. Clin. Oncol."}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/2\/394\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:56:03Z","timestamp":1760172963000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/9\/2\/394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,8]]},"references-count":194,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,2]]}},"alternative-id":["cells9020394"],"URL":"https:\/\/doi.org\/10.3390\/cells9020394","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,8]]}}}